Institutional Ownership Oric Pharmaceuticals, Inc. (ORIC)
This table provides information about the institutional ownership of Oric Pharmaceuticals, Inc. (ORIC). We have compiled data on the 146 institutions that hold shares in the stock, with a total of 91.8 Million shares, which have been reported (via 13F filing form) to have a value of $874 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Nextech Invest, Ltd.
Zurich, V8 |
Aug 14, 2025 Q2 2025 |
7,162,637
shares
|
$68.2 Million
13.76% of portfolio
|
Q2 2025
Added 35.51%
|
|
|
Vr Adviser, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
6,596,885
shares
|
$62.8 Million
13.26% of portfolio
|
Q2 2025
Added 107.28%
|
|
|
Viking Global Investors LP
|
Aug 14, 2025 Q2 2025 |
6,572,700
shares
|
$62.6 Million
0.21% of portfolio
|
Q1 2025
Added 48.33%
|
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
5,285,714
shares
|
$50.3 Million
7.95% of portfolio
|
Q1 2024
Added 23.33%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,830,880
shares
|
$46 Million
0.0% of portfolio
|
Q2 2024
Added 52.0%
|
|
|
Sr One Capital Management, LP
|
Aug 14, 2025 Q2 2025 |
4,514,929
shares
|
$43 Million
16.43% of portfolio
|
Q2 2025
New holding
|
|
|
Alkeon Capital Management LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
4,504,096
shares
|
$42.9 Million
0.08% of portfolio
|
Q2 2025
Added 12.49%
|
|
|
Nea Management Company, LLC
Timonium, MD |
Aug 14, 2025 Q2 2025 |
4,118,621
shares
|
$39.2 Million
3.47% of portfolio
|
Q2 2025
Added 87.59%
|
|
|
Column Group LLC
San Francisco, CA |
Aug 15, 2025 Q2 2025 |
3,540,777
shares
|
$33.7 Million
54.69% of portfolio
|
Q1 2024
Reduced 0.77%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Aug 13, 2025 Q2 2025 |
3,126,604
shares
|
$29.8 Million
6.72% of portfolio
|
Q2 2025
Added 50.28%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
3,124,693
shares
|
$29.7 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.84%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
2,850,641
shares
|
$27.1 Million
0.06% of portfolio
|
Q2 2025
New holding
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
2,762,915
shares
|
$26.3 Million
0.0% of portfolio
|
Q2 2025
Added 107.29%
|
|
|
First Turn Management, LLC
Del Mar, CA |
Aug 14, 2025 Q2 2025 |
2,009,923
shares
|
$19.1 Million
3.81% of portfolio
|
Q2 2025
Reduced 0.86%
|
|
|
Silverarc Capital Management, LLC
|
Aug 14, 2025 Q2 2025 |
1,800,829
shares
|
$17.1 Million
4.42% of portfolio
|
Q2 2025
Reduced 12.59%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
1,777,744
shares
|
$16.9 Million
0.03% of portfolio
|
Q2 2025
Reduced 11.43%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
1,729,378
shares
|
$16.5 Million
3.44% of portfolio
|
Q2 2025
Added 23.57%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,632,116
shares
|
$15.5 Million
0.0% of portfolio
|
Q2 2025
Reduced 25.7%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,618,068
shares
|
$15.4 Million
1.42% of portfolio
|
Q2 2025
Reduced 52.66%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
1,402,768
shares
|
$13.4 Million
0.0% of portfolio
|
Q2 2025
Added 174.04%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Aug 14, 2025 Q2 2025 |
1,278,454
shares
|
$12.2 Million
0.26% of portfolio
|
Q2 2025
Reduced 5.03%
|
|
|
Integral Health Asset Management, LLC
|
Aug 14, 2025 Q2 2025 |
1,250,000
shares
|
$11.9 Million
1.28% of portfolio
|
Q2 2025
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,108,460
shares
|
$10.6 Million
0.0% of portfolio
|
Q2 2025
Reduced 15.12%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
1,065,334
shares
|
$10.1 Million
0.57% of portfolio
|
Q2 2025
Reduced 24.45%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Aug 12, 2025 Q2 2025 |
1,042,558
shares
|
$9.93 Million
0.0% of portfolio
|
Q2 2025
Added 1.93%
|